Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Investors bring €40mm to immatics in second round

Executive Summary

New buyers DH Capital and OH Beteiligungen GMBH led a €40mm ($51.96mm) second round financing for cancer company immatics biotechnologies. Other new investors included National Technology Enterprises and KFW Banking, which were joined by existing backers 3i, Wellington Partners, Merifin Capital, Grazia Equity, L-EA/Seed, and EMBL Technology Fund.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies